ESMO 20th World Congress on Gastrointestinal Cancer has ended

Create Your Own Event

ESMO 20th World Congress on Gastrointestinal Cancer

13:30 PDT

Concurrent Lunch Mini-Symposia Level 1

14:45 PDT

Session I: Welcome, Selected Abstracts, and Opening Lecture Auditorium A, Level 0Mario Dicato • Josep Tabernero • Eric VanCutsem

14:46 PDT

Welcome and introduction Auditorium A, Level 0Mario Dicato • Josep Tabernero • Eric VanCutsem

14:50 PDT

Presentation of selected abstracts Auditorium A, Level 0

15:20 PDT

Opening Lecture: The microbiome in colon cancer Auditorium A, Level 0Herbert Tilg

15:50 PDT

Session II: Cancer of the Pancreas and Biliary Tract Auditorium A, Level 0Teresa Macarulla • Eileen O'Reilly

15:51 PDT

Genetics in pancreatic cancer: Implications for clinical practice Auditorium A, Level 0Zsofia K. Stadler

16:10 PDT

Are we making progress in surgery of the pancreas? Auditorium A, Level 0Baki Topal

16:30 PDT

Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas Auditorium A, Level 0Thierry Conroy

16:40 PDT

Is adjuvant or neo-adjuvant treatment for resectable pancreatic cancer the way to go? Auditorium A, Level 0Jordan D. Berlin • Pascal Hammel

17:00 PDT

Adjuvant treatment of pancreatic cancer Auditorium A, Level 0Thierry Conroy • Jean-Luc VanLaethem

17:20 PDT

Presentation of selected abstracts Auditorium A, Level 0

17:50 PDT

Improving the outcome of patients with metastatic pancreatic cancer Auditorium A, Level 0Philip A. Philip

18:10 PDT

New agents/strategies on the horizon in bile duct cancer Auditorium A, Level 0Michel Ducreux

19:00 PDT

Concurrent Evening Nonprofit Symposia Level 1

08:00 PDT

Session III: Meet the Expert Concurrent Presentations Level 1 Session IV: Presentation of Selected Abstracts on Non-Colorectal Cancer Auditorium B, Level 0Andrés Cervantes • Erika Martinelli Session V: Interpreting Clinical Trials Results Auditorium A, Level 0Axel Grothey • Rachel Riechelmann

08:01 PDT

Evaluating predictive markers and subgroups in clinical trials: Caution and best practices Auditorium A, Level 0 Advances in surgery of rectal cancer: Workshop Rooms 122-123, Level 1Andre D'Hoore • Rodrigo Perez Carcinoma of unknown origin Rooms 131-132, Level 1George Pentheroudakis New endoscopic screening tools: How do they help us? Rooms 120-121, Level 1Nadir Arber • Jaroslaw Regula Teaching on new evolutions in radiation oncology Rooms 133-134, Level 1Karin Haustermans • Vincenzo Valentini Presentations of selected abstracts Auditorium B, Level 0

08:20 PDT

Clinical interpretation and validity of clinical trials: When do they become practice changing? Auditorium A, Level 0Alberto Sobrero

08:40 PDT

What to use and to improve the evaluation of responses Auditorium A, Level 0Christoph Deroose • Raquel Perez-Lopez

09:10 PDT

Highlights of posters at ESMO GI on non-CRC Auditorium B, Level 0Erika Martinelli

09:20 PDT

Panel discussion Auditorium A, Level 0

09:30 PDT

Session VI: Esophageal and Gastric Cancers Auditorium A, Level 0Michel Ducreux • Kei Muro

09:31 PDT

Management of squamous cell cancer for the esophagus Auditorium A, Level 0David H. Ilson • Florian Lordick

09:55 PDT

Locally advanced GE junction cancer Auditorium A, Level 0David Cunningham • David H. Ilson

10:20 PDT

Is FLOT the only standard in the perioperative setting for gastric cancer? Auditorium A, Level 0Andrés Cervantes

10:30 PDT

Keynote Lecture: Progress in unraveling the molecular taxonomy in oesophageal and gastric cancer Auditorium A, Level 0Patrick Tan

11:00 PDT

Break and poster viewing Exhibition Hall Poster discussion guided tours Exhibition HallBrigetta Ma • Eileen O'Reilly • Thomas Seufferlein

11:30 PDT

Session VII: Gastric Cancer Auditorium A, Level 0Fatima Carneiro • David Cunningham

11:31 PDT

Keynote Lecture: Hereditary aspects of gastric cancer Auditorium A, Level 0Fatima Carneiro

12:00 PDT

Presentation of selected abstracts Auditorium A, Level 0

12:30 PDT

Metastatic gastric cancer: Where are we with check-point inhibitors in gastric cancer? Auditorium A, Level 0Kei Muro

12:50 PDT

Metastatic gastric cancer: New targeted agents in metastatic gastric cancer Auditorium A, Level 0David H. Ilson

13:10 PDT

13:25 PDT

Concurrent Lunch Symposia Level 1

15:10 PDT

Session VIII: Diseases and Cancers of the Liver Auditorium A, Level 0Thomas Seufferlein • Chris Verslype

15:11 PDT

Keynote Lecture: Progress in liver transplantation in GI malignancies: HCC, biliary tract, NET, colon Auditorium A, Level 0René Adam

15:40 PDT

Tumor board on HCC Auditorium A, Level 0Chris Verslype • Ghassan Abou-Alfa • René Adam • Jordan D. Berlin • Christoph Deroose • Thomas Seufferlein

16:10 PDT

Presentation of selected abstract Auditorium A, Level 0

16:20 PDT

How to integrate new agents in HCC Auditorium A, Level 0Ghassan Abou-Alfa

16:40 PDT

Break and poster viewing Exhibition Hall

17:10 PDT

Session IX: Expert Highlights: What is New in This disease? Auditorium A, Level 0Nadir Arber • Mario Dicato

17:11 PDT

What is new in NET in the last 12 months? Auditorium A, Level 0Marianne Pavel

17:30 PDT

What is new in GIST in the last 12 months? Auditorium A, Level 0John Zalcberg

17:50 PDT

What is new in anal cancer in the last 12 months? Auditorium A, Level 0Michel Ducreux

18:10 PDT

What is new in bile duct cancer in the last 12 months? Auditorium A, Level 0Juan W. Valle

18:30 PDT

Keynote Lecture: Protein Biosynthesis in Healthy Cells and in Cancer Cells Auditorium A, Level 0Ada E. Yonath

19:00 PDT

20th Anniversary Celebration Reception Banquet Hall, Level 2

08:00 PDT

Session XIII: Prevention and Screening of Colon Cancer Auditorium B, Level 0Nadir Arber • Jaroslaw Regula Session X: Case Discussion on Liver Metastases Rooms 120-121, Level 1 Session XII: ESMO Session: Focus on Young Medical Oncologists Rooms 133-134, Level 1Guillem Argilés • Josep Tabernero Session XI: Presentation of Selected Abstracts: Colorectal Cancer Auditorium A, Level 0Johanna Bendell • Roberto Labianca

08:01 PDT

Presentation of selected abstract Auditorium B, Level 0 Role of Fusobacterium Nucleatum and intestinal microbiota in CRC pathogenesis and evolution Rooms 133-134, Level 1Paolo G. Nuciforo Presentation of selected abstracts Auditorium A, Level 0Roberto Labianca Locoregional treatment for liver metastases: How to choose within the toolbox and when to go for locoregional treatments Rooms 120-121, Level 1Bernard Nordlinger • Peter Gibbs • Thomas Gruenberger • Karin Haustermans • Rachel Riechelmann • Julien Taieb

08:10 PDT

Genetic testing for familial and hereditary colorectal cancer Auditorium B, Level 0Zsofia K. Stadler

08:20 PDT

Drugging TGF-beta pathway as a way to foster immune responses in mCRC Rooms 133-134, Level 1Daniele Tauriello

08:30 PDT

Screening for colon cancer: What has been achieved in 2018 and new prospects Auditorium B, Level 0Jaroslaw Regula

08:40 PDT

The importance of having a mentor in the European oncology environment Rooms 133-134, Level 1Andrés Cervantes Presentation of selected abstracts Auditorium A, Level 0

08:50 PDT

Will chemoprevention become a reality? Auditorium B, Level 0Nadir Arber

09:00 PDT

How to find a good mentor in Europe Rooms 133-134, Level 1Erika Martinelli

09:30 PDT

Session XIV: Highlights Auditorium A, Level 0Mario Dicato • Eric VanCutsem

09:31 PDT

Keynote Lecture: Understanding relevant immune mechanisms in GI oncology Auditorium A, Level 0Pierre Coulie

10:00 PDT

Keynote Lecture: Coping with escalating healthcare costs in 2018 and beyond Auditorium A, Level 0Josep Tabernero

10:30 PDT

Travel Grant Award Ceremony Auditorium A, Level 0

10:35 PDT

Break and poster viewing Exhibition Hall Poster discussion guided tours Exhibition HallBernard Nordlinger • Gerald Prager • Thomas Seufferlein

11:05 PDT

Session XV: Multimodality Therapy for Rectal Cancer Auditorium A, Level 0Regina G.H. Beets-Tan • Karin Haustermans

11:06 PDT

Keynote Lecture: TME surgery as seen by the creator Auditorium A, Level 0R.J. (Bill) Heald

11:35 PDT

Debate: This house believes multiparametric MRI is the holy grail for organ preservation in rectal cancer Auditorium A, Level 0Regina G.H. Beets-Tan • Karin Haustermans

11:55 PDT

Rectal cancer after neoadjuvant therapy with complete clinical response Auditorium A, Level 0Rodrigo Perez • Eric Rullier

12:15 PDT

Evolution and innovations in rectal cancer surgery Auditorium A, Level 0Andre D'Hoore

12:35 PDT

Presentation of selected abstract Auditorium A, Level 0

12:45 PDT

13:00 PDT

Concurrent Lunch Symposia Level 1

14:45 PDT

Session XVI: Molecular Biology in CRC Auditorium A, Level 0Fortunato Ciardiello • Brigetta Ma

14:46 PDT

How to approach the patient with a BRAF mutant tumor Auditorium A, Level 0Chloe Atreya

15:05 PDT

Current status and perspectives on liquid biopsies in GI cancer Auditorium A, Level 0Fortunato Ciardiello

15:25 PDT

Is circulating DNA relevant in stage II colon cancer? Auditorium A, Level 0Peter Gibbs

15:45 PDT

New insights on the molecular and immunologic classifications in CRC 8 Auditorium A, Level 0Sabine Tejpar

16:05 PDT

Is broad NGS testing useful in patients with metastatic colorectal cancer? Auditorium A, Level 0Rodrigo Dienstmann • Howard Hochster

16:35 PDT

Presentation of selected abstract Auditorium A, Level 0

16:45 PDT

Break and poster viewing Exhibition Hall

17:15 PDT

Session XVII: Immune Mechanisms and Immune Therapy in GI Cancer Auditorium A, Level 0Ali Shamseddine • Alberto Sobrero

17:16 PDT

Presentation of selected abstract Auditorium A, Level 0

17:25 PDT

Highlights of Posters at ESMO GI on colorectal cancer Auditorium A, Level 0Takayuki Yoshino

17:40 PDT

How to increase immunogenicity in MSS CRC Auditorium A, Level 0Guillem Argilés

18:00 PDT

Are we making progress with Immuno-Oncologic in pancreatic cancer? Auditorium A, Level 0Eileen O'Reilly

18:20 PDT

Session XVIII: Impact of New Evolutions in GI Oncology in Emerging Regions Auditorium A, Level 0

18:21 PDT

What do the new evolutions in GI cancer mean for my practice? Auditorium A, Level 0Jorge Gallardo • Brigetta Ma • Ali Shamseddine

08:30 PDT

Session XIX: Colorectal Cancer: How to Deal with New Treatments Auditorium A, Level 0Alberto Sobrero • Josep Tabernero

08:31 PDT

How can we deal with the explosion of new treatments Auditorium A, Level 0Jorge Camarero • Jean-Yves Douillard • Steven Lemery

09:30 PDT

Session XX: Colorectal Cancer Auditorium A, Level 0Josep Tabernero • Eric VanCutsem

09:31 PDT

Presentation of selected abstracts Auditorium A, Level 0David Cunningham

10:10 PDT

Explaining the unexplainable: CALGB vs FIRE-3 discrepant data Auditorium A, Level 0Dan Aderka

10:25 PDT

The left versus right colon cancer story: What is the truth? Auditorium A, Level 0Volker Heinemann

10:40 PDT

11:10 PDT

Session XX: Colorectal Cancer (Continued) Auditorium A, Level 0Josep Tabernero • Eric VanCutsem

11:11 PDT

How to improve on the outcome in RAS mutant tumors Auditorium A, Level 0Heinz-Josef Lenz

11:30 PDT

Presentation of selected abstracts Auditorium A, Level 0Ramon Salazar

12:10 PDT

Can we refine the selection for adjuvant treatment in stage II colon cancer? Auditorium A, Level 0Axel Grothey

12:30 PDT

Presentation of selected abstract Auditorium A, Level 0

12:40 PDT

Can we refine the selection for adjuvant treatment in stage III colon cancer? Auditorium A, Level 0Thierry André

13:10 PDT

13:25 PDT

Concurrent Lunch Symposia Level 1

15:10 PDT

Session XXI: From 1999 to 2018 and Beyond Auditorium A, Level 0Mario Dicato • Bernard Nordlinger

15:11 PDT

Celebration Lecture: The history of GI cancer: What has been achieved over the last 20 years? Auditorium A, Level 0Aimery DeGramont

15:40 PDT

Multidisciplinary tumor board on resectable and borderline/potentially resectable liver metastases Auditorium A, Level 0Eric VanCutsem • Axel Grothey • Erika Martinelli • Bernard Nordlinger

16:10 PDT

Molecular and hereditary tumor board Auditorium A, Level 0Eric VanCutsem • Heinz-Josef Lenz • Brigetta Ma • Ramon Salazar • Zsofia K. Stadler

16:40 PDT

Session XXII: Report on Expert Consensus Discussion: The Strategy in Synchronous Oligometastatic Colorectal Cancer Auditorium A, Level 0

16:41 PDT

Presentation of outcome of expert consensus discussion Auditorium A, Level 0Mario Dicato • Josep Tabernero • Eric VanCutsem